Few Danish BA.2.75 cases
BA.2.75, which is a subvariant of BA.2, was first observed in May 2022 in India, where the largest increase in infections with BA.2.75 has occurred to this date. Since May 2022 this variant has been observed in 27 countries.
BA.2.75 is classified by ECDC as a “variant under monitoring” and has gathered much attention both nationally and internationally. One of the reasons for this is nine changes in the spike protein of this subvariant, which may affect this variants ability to evade immunity and transmissibility.
Few Danish cases and no signs of an increase at the moment
In Denmark 13 cases has so far been observed in the period between the 8th to 29th of July 2022, reports Statens Serum Institut (SSI).
“Data on this variant is still very sparse, but the low number of cases does not indicate a wider circulation in the population. At the moment there is also no significant increase in the number of cases. Statens Serum Institut can therefore not conclude whether BA.2.75 is capable of outcompeting BA.5”, says director Henrik Ullum.
It is still BA.5 that is the dominant variant in Denmark. BA.5 made up 92% of all sequenced samples in week 30, and there is at this moment no signs that other variants is in significant growth.
Press contacts
Contact Statens Serum Institut’s press department at telephone number +45 2260 1123 or e-mail presse@ssi.dk